Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Brain ; 134(Pt 12): 3516-29, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22067542

ABSTRACT

Nemaline myopathy, the most common congenital myopathy, is caused by mutations in genes encoding thin filament and thin filament-associated proteins in skeletal muscles. Severely affected patients fail to survive beyond the first year of life due to severe muscle weakness. There are no specific therapies to combat this muscle weakness. We have generated the first knock-in mouse model for severe nemaline myopathy by replacing a normal allele of the α-skeletal actin gene with a mutated form (H40Y), which causes severe nemaline myopathy in humans. The Acta1(H40Y) mouse has severe muscle weakness manifested as shortened lifespan, significant forearm and isolated muscle weakness and decreased mobility. Muscle pathologies present in the human patients (e.g. nemaline rods, fibre atrophy and increase in slow fibres) were detected in the Acta1(H40Y) mouse, indicating that it is an excellent model for severe nemaline myopathy. Mating of the Acta1(H40Y) mouse with hypertrophic four and a half LIM domains protein 1 and insulin-like growth factor-1 transgenic mice models increased forearm strength and mobility, and decreased nemaline pathologies. Dietary L-tyrosine supplements also alleviated the mobility deficit and decreased the chronic repair and nemaline rod pathologies. These results suggest that L-tyrosine may be an effective treatment for muscle weakness and immobility in nemaline myopathy.


Subject(s)
Muscle Weakness/genetics , Muscle, Skeletal/pathology , Myopathies, Nemaline/drug therapy , Myopathies, Nemaline/genetics , Tyrosine/therapeutic use , Animals , Disease Models, Animal , Hand Strength , Hypertrophy/genetics , Hypertrophy/pathology , Mice , Mice, Transgenic , Muscle Contraction/genetics , Muscle Weakness/drug therapy , Muscle Weakness/pathology , Mutation , Myopathies, Nemaline/pathology , Phenotype
2.
Endocrinology ; 149(5): 2403-10, 2008 May.
Article in English | MEDLINE | ID: mdl-18258678

ABSTRACT

Stanniocalcin (STC), a secreted glycoprotein, was first studied in fish as a classical hormone with a role in regulating serum calcium levels. There are two closely related proteins in mammals, STC1 and STC2, with functions that are currently unclear. Both proteins are expressed in numerous mammalian tissues rather than being secreted from a specific endocrine gland. No phenotype has been detected yet in Stc1-null mice, and to investigate whether Stc2 could have compensated for the loss of Stc1, we have now generated Stc2(-/-) and Stc1(-/-) Stc2(-/-) mice. Although Stc1 is expressed in the ovary and lactating mouse mammary glands, like the Stc1(-/-) mice, the Stc1(-/-) Stc2(-/-) mice had no detected decrease in fertility, fecundity, or weight gain up until weaning. Serum calcium and phosphate levels were normal in Stc1(-/-) Stc2(-/-) mice, indicating it is unlikely that the mammalian stanniocalcins have a major physiological role in mineral homeostasis. Mice with Stc2 deleted were 10-15% larger and grew at a faster rate than wild-type mice from 4 wk onward, and the Stc1(-/-) Stc2(-/-) mice had a similar growth phenotype. This effect was not mediated through the GH/IGF-I axis. The results are consistent with STC2 being a negative regulator of postnatal growth.


Subject(s)
Glycoproteins/physiology , Growth and Development/genetics , Animals , Animals, Newborn , Body Weight/genetics , Bone Development/genetics , Crosses, Genetic , Female , Glycoproteins/genetics , Intercellular Signaling Peptides and Proteins , Intracellular Signaling Peptides and Proteins , Male , Mice , Mice, Inbred BALB C , Mice, Knockout , Motor Activity/genetics , Muscle, Skeletal/physiology , Organ Size/genetics , Reproduction/genetics , Sex Characteristics
3.
Adv Exp Med Biol ; 642: 66-77, 2008.
Article in English | MEDLINE | ID: mdl-19181094

ABSTRACT

Thin filament integrity is important for the ordered structure and function of skeletal muscles. Mutations within genes that encode thin filament and thin filament-associated proteins can cause muscle disruption, fiber atrophy and alter fiber type composition, leading to muscle weakness. Analyses of patient biopsy samples and tissue culture systems provide rapid methods for studying disease-causing mutations. However, there are limitations to these techniques. Although time consuming, many laboratories are generating and utilizing animal models, in particular the mouse, to study the disease process of various myopathies. This chapter reviews the use of mouse models for thin filament diseases of skeletal muscle and in particular, concentrates on what has been achieved through the generation and characterization of transgenic and knock-in mouse models for the congenital thin filament disease nemaline myopathy. We will review potential therapies that have been trialled on the nemaline models, providing indications for future directions for the treatment of nemaline myopathy patients and muscle weakness in general.


Subject(s)
Muscle Fibers, Skeletal/metabolism , Muscular Diseases/metabolism , Animals , Disease Models, Animal , Humans , Mice , Muscle Proteins/genetics , Muscle Proteins/metabolism , Muscular Diseases/genetics , Muscular Diseases/pathology , Mutation/genetics
4.
Hum Mol Genet ; 15(17): 2603-12, 2006 Sep 01.
Article in English | MEDLINE | ID: mdl-16877500

ABSTRACT

Nemaline myopathy (NM), the most common non-dystrophic congenital myopathy, is a variably severe neuromuscular disorder for which no effective treatment is available. Although a number of genes have been identified in which mutations can cause NM, the pathogenetic mechanisms leading to the phenotypes are poorly understood. To address this question, we examined gene expression patterns in an NM mouse model carrying the human Met9Arg mutation of alpha-tropomyosin slow (Tpm3). We assessed five different skeletal muscles from affected mice, which are representative of muscles with differing fiber-type compositions, different physiological specializations and variable degrees of pathology. Although these same muscles in non-affected mice showed marked variation in patterns of gene expression, with diaphragm being the most dissimilar, the presence of the mutant protein in nemaline muscles resulted in a more similar pattern of gene expression among the muscles. This result suggests a common process or mechanism operating in nemaline muscles independent of the variable degrees of pathology. Transcriptional and protein expression data indicate the presence of a repair process and possibly delayed maturation in nemaline muscles. Markers indicative of satellite cell number, activated satellite cells and immature fibers including M-Cadherin, MyoD, desmin, Pax7 and Myf6 were elevated by western-blot analysis or immunohistochemistry. Evidence suggesting elevated focal repair was observed in nemaline muscle in electron micrographs. This analysis reveals that NM is characterized by a novel repair feature operating in multiple different muscles.


Subject(s)
Muscle, Skeletal/pathology , Myopathies, Nemaline/metabolism , Myopathies, Nemaline/pathology , Animals , Disease Progression , Gene Expression Profiling , Mice , Mice, Transgenic , Microscopy, Electron , Muscle, Skeletal/metabolism , Muscle, Skeletal/ultrastructure , Myofibrils/metabolism , Myofibrils/pathology , Oligonucleotide Array Sequence Analysis , Signal Transduction
5.
Hum Mol Genet ; 13(21): 2633-45, 2004 Nov 01.
Article in English | MEDLINE | ID: mdl-15367485

ABSTRACT

Patients with the inherited muscle disease nemaline myopathy experience prolonged muscle weakness following periods of immobility. We have examined endurance exercise as a means of improving recovery following muscle inactivity in our alpha-tropomyosin(slow)(Met9Arg)-transgenic mouse model of nemaline myopathy. Physical inactivity, mimicked using a hindlimb immobilization protocol, resulted in fiber atrophy and severe muscle weakness. Following immobilization, the nemaline mice (NM) were weaker than WT mice but regained whole-body strength with exercise training. The disuse-induced weakness and the regain of strength with exercise in NM were associated with the respective formation and resolution of nemaline rods, suggesting a role for rods in muscle weakness. Muscles from NM did not show the typical features of muscle repair during chronic stretch-immobilization of the soleus muscle (regeneration occurred with relative lack of centralized nuclei). This indicates that the normal process of regeneration may be altered in nemaline myopathy and may contribute to poor recovery. In conclusion, endurance exercise can alleviate disuse-induced weakness in NM. The altered myofiber repair process in the nemaline mice may be a response to primary myofibrillar damage that occurs in nemaline myopathy and is distinct from the classical repair in muscular dystrophy resulting from plasma membrane defects.


Subject(s)
Muscle Fibers, Slow-Twitch/physiology , Muscle Weakness/physiopathology , Myopathies, Nemaline/physiopathology , Physical Conditioning, Animal , Animals , Disease Models, Animal , Electrophoresis, Polyacrylamide Gel , Humans , Immobilization/methods , Immunohistochemistry , Mice , Mice, Transgenic , Muscle Weakness/genetics , Muscle Weakness/pathology , Muscle, Skeletal/pathology , Muscle, Skeletal/physiopathology , Muscle, Skeletal/ultrastructure , Myopathies, Nemaline/genetics , Myosin Heavy Chains/chemistry , Myosin Heavy Chains/metabolism , Physical Endurance/physiology , Time Factors
6.
Dev Comp Immunol ; 26(7): 599-602, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12074924

ABSTRACT

Marsupials, unlike eutherians, are born immunologically immature, without circulating lymphocytes or organised lymphoid tissue. Their immune response develops while they are in the pouch not in the uterus. In this study, the onset time of immunoglobulin expression in Trichosurus vulpecula pouch young was estimated by reverse transcription polymerase chain reaction. As in eutherian species, IgM heavy chain transcripts were detected first, at day 10 post partum. The first switched transcript, detected at day 18, was Calpha. Cgamma and Cvarepsilon transcripts were not present at day 72, but were seen at day 103, approximately corresponding to the time of release of the teat and exposure to new antigens, as well as the time of the loss of capacity to absorb maternal Igs through the gut.


Subject(s)
Immunoglobulin Heavy Chains/genetics , Opossums/immunology , Animals , Gene Expression Profiling , Immunoglobulin Constant Regions/genetics , Immunoglobulin M/genetics , Immunoglobulin epsilon-Chains/genetics , Immunoglobulin gamma-Chains/genetics , Immunoglobulin mu-Chains/genetics , Opossums/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...